Herpes Zoster - 33 Studies Found Completed : Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy : Herpes Zoster : 2013-02-14 : Biological: GSK 1437173A 2 dos Active, not recruiting : Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older : Herpes Zoster : 2016-04-07 : Biological: Herpes Zoster Vaccine GSK1437173A Intramuscular injection Completed : Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older : Herpes Zoster : 2014-01-23 : Biological: Herpes Zoster vaccine GSK 1437173A Completed : Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older : Herpes Zoster : 2010-07-15 : Biological: Herpes Zoster Vaccine GSK1437173A Completed : Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older : Herpes Zoster : 2014-01-23 : Biological: Herpes Zoster vaccine GSK 1437173A Not yet recruiting : Zoster Eye Disease Study : Herpes Zoster Ophthalmicus : 2017-04-26 : Drug: Masked Placebo Oral Plac Recruiting : Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis : Herpes Zoster Keratitis : 2015-03-03 : Drug: gancyclovir gel 0.15% ga
